Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.00%
SPX
+0.52%
IXIC
+0.52%
FTSE
-0.32%
N225
+0.84%
AXJO
+0.33%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
90.52M
Dividend Yield
0.00%
P/E Ratio
-1.80
EPS
-3.64
Revenue
-
Avg. Volume
128.27K

About

What does CRBP do?
Corbus Pharmaceuticals, based in Norwood, Massachusetts, focuses on developing therapies for rare inflammatory diseases and cancer, with a pipeline including CRB-701 and CRB-601. The company went public on October 24, 2014, and employs 19 staff.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Massachusetts, USA
Website
http://www.corbuspharma.com

Recently from Cashu

publisher logo
Cashu

Corbus Pharmaceuticals Holdings Advances Novel Therapies for Rare Inflammatory and Fibrotic Diseases

3 days ago
publisher logo
Cashu

Request for Content on Corbus Pharmaceuticals Holdings for Summary Creation

14 days ago
publisher logo
Cashu

Corbus Pharmaceuticals Holdings: Key Developments and Future Outlook in Biopharmaceuticals

24 days ago
Stocks
Health Care
crbp
Corbus Pharmaceuticals Holdings
CRBP
-0.53 (-6.61%)
7.49
USD
At close at Jun 27, 20:39 UTC
Summary
News
Signals
Benchmarks
Financials